Bank of New York Mellon Corp Buys 6,690 Shares of Harrow, Inc. (NASDAQ:HROW)

Bank of New York Mellon Corp grew its position in Harrow, Inc. (NASDAQ:HROW) by 8.4% during the fourth quarter, HoldingsChannel.com reports. The fund owned 86,447 shares of the company’s stock after acquiring an additional 6,690 shares during the quarter. Bank of New York Mellon Corp’s holdings in Harrow were worth $2,900,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Quest Partners LLC bought a new position in shares of Harrow during the third quarter valued at approximately $29,000. Virtu Financial LLC acquired a new position in shares of Harrow during the third quarter worth $271,000. Principal Financial Group Inc. purchased a new stake in shares of Harrow during the third quarter worth about $329,000. Zurcher Kantonalbank Zurich Cantonalbank acquired a new stake in shares of Harrow during the third quarter worth $338,000. Finally, China Universal Asset Management Co. Ltd. raised its stake in shares of Harrow by 10.7% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 7,552 shares of the company’s stock worth $253,000 after purchasing an additional 727 shares during the last quarter. 72.76% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

HROW has been the topic of a number of recent research reports. HC Wainwright restated a “buy” rating and issued a $57.00 target price on shares of Harrow in a research note on Tuesday. B. Riley decreased their price target on shares of Harrow from $73.00 to $69.00 and set a “buy” rating on the stock in a research note on Wednesday, December 4th.

Harrow Stock Performance

Shares of Harrow stock opened at $28.09 on Friday. The firm has a market cap of $1.00 billion, a PE ratio of -29.88 and a beta of 0.69. Harrow, Inc. has a 52 week low of $9.86 and a 52 week high of $59.23. The business’s fifty day simple moving average is $29.67 and its 200-day simple moving average is $38.48. The company has a quick ratio of 1.44, a current ratio of 1.55 and a debt-to-equity ratio of 3.23.

Harrow Company Profile

Harrow, Inc operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company was formerly known as Imprimis Pharmaceuticals, Inc and changed its name to Harrow Health, Inc in December 2018. Harrow Health, Inc was incorporated in 2006 and is headquartered in Nashville, Tennessee.